This $767,193 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to identify undiagnosed Alzheimer's disease (AD) in underserved Hispanic/Latino and African American populations. The key products and services to be delivered under this award include: Identifying disease trajectories associated with AD to help predict undiagnosed cases, while accounting for underdiagnosis bias in the target populations (Aims 1-2). Integrating...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $311,341 to the University of Southern California to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults. The project involves two main phases. The first phase will conduct semi-structured interviews with a cohort of Latino adults and Latino patients with AD/ADRD and their caregivers to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $499,796 to Clear Session, Inc. to develop an innovative digital visualization tool to improve communication between clinicians, Latino Alzheimer's disease and related dementias (ADRD) patients, and their caregivers. The tool is designed to be linguistically and culturally tailored to break down complex medical information in a clear and comprehensible way, thereby enhancing healthcare...
This $1,010,230 Project Grant award, funded by the National Institute on Aging (CFDA 93.866 Aging Research), supports research to evaluate the feasibility and effectiveness of a culturally-adapted mindfulness-based program (MBP) for Latinx older adults at risk of developing Alzheimer's disease (AD). The Washington University is leading this R61 research project, which aims to address disparities in AD burden among Latinx communities through a new MBP intervention tailored to their specific...
This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
The National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), awarded a $356,974 project grant to Indiana University to culturally adapt a mobile caregiver intervention for Hispanic dementia caregivers. The project aims to conduct a needs assessment, adapt the "Brain CarENotes" mobile application to be culturally relevant, and pilot the adapted intervention to ensure a future randomized controlled trial will be sufficiently powered to detect reductions in...
This $129,411 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and evaluate novel digital initiatives to improve the inclusion of minoritized older adults, specifically Black/African American and Latinx/a/o populations, in Alzheimer's disease and related dementia (AD/ADRD) research. The key objectives are to: 1) Identify theory-based factors associated with greater intention to participate in different AD/ADRD research settings among this...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $811,228 Project Grant to B.A. Maze, Inc. on September 25, 2024. The grant will fund the development of the At-Home Health Station (AHS), a plug-and-play modular system designed to simplify digital experiences for individuals with cognitive impairment or Alzheimer's disease and related dementias. The AHS system aims to promote health function and independence through remote patient...
The National Institute on Aging (NIA) awarded a Project Grant under CFDA 93.866 - Aging Research to the Northern California Institute for Research and Education, Inc. (NCIRE) for $1,680,653. The grant, awarded on August 1, 2024, supports the next phase of the U.S. Deprescribing Research Network, a national initiative focused on expanding the quality, quantity, and translational impact of research on deprescribing medications for older adults, particularly those with conditions like Alzheimer's...
The National Institute on Aging (NIA), through the Aging Research federal grant program (CFDA 93.866), awarded a $1,128,979 project grant to the University of Southern California (USC) to study the impact of ethnicity on the utility of plasma amyloid and tau biomarkers to predict Alzheimer's disease. The project aims to comprehensively measure phosphorylated tau (p-tau217) levels in plasma samples from the Health and Aging Brain Study-Health Disparities (HABS-HD) cohort, and investigate how...